Prescription drugs

Speaker of the House Nancy Pelosi, D-Calif., arrives for a closed-door meeting with the House Democratic Caucus, Wednesday, Sept. 18, 2019, at the Capitol in Washington. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 1:16 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi, trying to seize the agenda on a top consumer issue, announced an ambitious prescription drug plan Thursday that would allow Medicare to negotiate prices for seniors and younger people. The proposal would direct Medicare to bargain over as many as 250,...
Read More
On this Sept. 12, 2019, photo, House Speaker Nancy Pelosi, D-Calif., speaks at the Capitol in Washington. The good news is that it doesn’t look like a bitterly polarized Washington will stumble into another government shutdown. But as Democrats controlling the House unveil a stopgap, government-wide spending bill to keep the lights on and pay the troops, there’s scant evidence that power sharing in the U.S. Capitol will produce further legislative accomplishments anytime soon. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 10:50 am
WASHINGTON (AP) — Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to...
Read More
On this Sept. 12, 2019, photo, House Speaker Nancy Pelosi, D-Calif., speaks at the Capitol in Washington. The good news is that it doesn’t look like a bitterly polarized Washington will stumble into another government shutdown. But as Democrats controlling the House unveil a stopgap, government-wide spending bill to keep the lights on and pay the troops, there’s scant evidence that power sharing in the U.S. Capitol will produce further legislative accomplishments anytime soon. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 10:09 am
WASHINGTON (AP) — Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to...
Read More
On this Sept. 12, 2019, photo, House Speaker Nancy Pelosi, D-Calif., speaks at the Capitol in Washington. The good news is that it doesn’t look like a bitterly polarized Washington will stumble into another government shutdown. But as Democrats controlling the House unveil a stopgap, government-wide spending bill to keep the lights on and pay the troops, there’s scant evidence that power sharing in the U.S. Capitol will produce further legislative accomplishments anytime soon. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 9:02 am
WASHINGTON (AP) — Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
September 18, 2019 - 1:13 am
NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
September 17, 2019 - 5:24 pm
WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:42 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:20 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 3:03 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 7:29 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More

Pages